Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

Recent data on intratumor estrogens in breast cancer.

Lønning PE, Haynes BP, Straume AH, Dunbier A, Helle H, Knappskog S, Dowsett M.

Steroids. 2011 Jul;76(8):786-91. doi: 10.1016/j.steroids.2011.02.040. Epub 2011 Mar 31. Review.

PMID:
21439992
2.

Role of steroid sulfatase in local formation of estrogen in post-menopausal breast cancer patients.

Nakata T, Takashima S, Shiotsu Y, Murakata C, Ishida H, Akinaga S, Li PK, Sasano H, Suzuki T, Saeki T.

J Steroid Biochem Mol Biol. 2003 Sep;86(3-5):455-60.

PMID:
14623544
3.

Breast cancer tissue estrogens and their manipulation with aromatase inhibitors and inactivators.

Geisler J.

J Steroid Biochem Mol Biol. 2003 Sep;86(3-5):245-53. Review.

PMID:
14623518
4.

Tissue estradiol is selectively elevated in receptor positive breast cancers while tumour estrone is reduced independent of receptor status.

Lønning PE, Helle H, Duong NK, Ekse D, Aas T, Geisler J.

J Steroid Biochem Mol Biol. 2009 Oct;117(1-3):31-41. doi: 10.1016/j.jsbmb.2009.06.005. Epub 2009 Jul 8.

PMID:
19591931
5.

Enzymatic control of estrogen production in human breast cancer: relative significance of aromatase versus sulfatase pathways.

Santen RJ, Leszczynski D, Tilson-Mallet N, Feil PD, Wright C, Manni A, Santner SJ.

Ann N Y Acad Sci. 1986;464:126-37. Review.

PMID:
3524346
6.

Exploring breast cancer estrogen disposition: the basis for endocrine manipulation.

Lønning PE, Haynes BP, Straume AH, Dunbier A, Helle H, Knappskog S, Dowsett M.

Clin Cancer Res. 2011 Aug 1;17(15):4948-58. doi: 10.1158/1078-0432.CCR-11-0043. Epub 2011 Jul 26. Review.

7.

Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells.

Shields-Botella J, Chetrite G, Meschi S, Pasqualini JR.

J Steroid Biochem Mol Biol. 2005 Jan;93(1):1-13. Epub 2005 Jan 26. Review.

PMID:
15748827
8.

Breast cancer aromatase expression evaluated by the novel antibody 677: correlations to intra-tumor estrogen levels and hormone receptor status.

Geisler J, Suzuki T, Helle H, Miki Y, Nagasaki S, Duong NK, Ekse D, Aas T, Evans DB, Lønning PE, Sasano H.

J Steroid Biochem Mol Biol. 2010 Feb 28;118(4-5):237-41. doi: 10.1016/j.jsbmb.2009.10.010. Epub 2009 Oct 31.

PMID:
19883757
9.

Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.

Pasqualini JR, Chetrite GS.

J Steroid Biochem Mol Biol. 2005 Feb;93(2-5):221-36. Review.

PMID:
15860265
10.

The potential role of estrogen in aromatase regulation in the breast.

Yue W, Berstein LM, Wang JP, Clark GM, Hamilton CJ, Demers LM, Santen RJ.

J Steroid Biochem Mol Biol. 2001 Dec;79(1-5):157-64.

PMID:
11850220
12.

Estradiol and progesterone receptor levels in human breast cancer in relation to cytosol and plasma estrogen level.

Drafta D, Prişcu A, Neacşu E, Gangură M, Schindler AE, Stroe E, Anghel C, Panaitescu G.

J Steroid Biochem. 1983 Apr;18(4):459-63.

PMID:
6834830
13.

Intratumoral estrogen disposition in breast cancer.

Haynes BP, Straume AH, Geisler J, A'Hern R, Helle H, Smith IE, Lønning PE, Dowsett M.

Clin Cancer Res. 2010 Mar 15;16(6):1790-801. doi: 10.1158/1078-0432.CCR-09-2481. Epub 2010 Mar 9.

14.

On the significance of in situ production of oestrogens in human breast cancer tissue.

Blankenstein MA, Maitimu-Smeele I, Donker GH, Daroszewski J, Milewicz A, Thijssen JH.

J Steroid Biochem Mol Biol. 1992 Mar;41(3-8):891-6.

PMID:
1314086
15.

The potential of aromatase inhibitors in breast cancer prevention.

Santen RJ, Yue W, Naftolin F, Mor G, Berstein L.

Endocr Relat Cancer. 1999 Jun;6(2):235-43. Review.

16.

Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis.

Yue W, Santen RJ, Wang JP, Li Y, Verderame MF, Bocchinfuso WP, Korach KS, Devanesan P, Todorovic R, Rogan EG, Cavalieri EL.

J Steroid Biochem Mol Biol. 2003 Sep;86(3-5):477-86. Review.

PMID:
14623547
17.

Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.

Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE.

J Natl Cancer Inst. 2004 Dec 15;96(24):1856-65.

PMID:
15601642
18.

Aromatase and breast cancer susceptibility.

Probst-Hensch NM, Ingles SA, Diep AT, Haile RW, Stanczyk FZ, Kolonel LN, Henderson BE.

Endocr Relat Cancer. 1999 Jun;6(2):165-73.

19.

A prospective study of endogenous estrogens and breast cancer in postmenopausal women.

Toniolo PG, Levitz M, Zeleniuch-Jacquotte A, Banerjee S, Koenig KL, Shore RE, Strax P, Pasternack BS.

J Natl Cancer Inst. 1995 Feb 1;87(3):190-7.

PMID:
7707406
20.

Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients.

Pasqualini JR, Chetrite G, Blacker C, Feinstein MC, Delalonde L, Talbi M, Maloche C.

J Clin Endocrinol Metab. 1996 Apr;81(4):1460-4.

PMID:
8636351

Supplemental Content

Support Center